SKIN.BK Skin Laboratory PCL
- Market cap
- THB 112M
- P/E
- -
- P/B
- 1.30x
- ROE
- -34.0%
- Dividend yield
- 14.69%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is SKIN.BK undervalued?
Graham numberThe Graham number of Skin Laboratory PCL cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Skin Laboratory PCL fundamental analysis
No fundamental analysis for Skin Laboratory PCL yet.
Skin Laboratory PCL stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Skin Laboratory PCL
Skin Laboratory Public Company Limited manufactures and distributes beauty products in Thailand and internationally. The company offers skincare products, beauty creams, cosmetics, and dietary supplements under the Skinsista and Dermie brand names. It sells its products through online channels and stores. The company was incorporated in 2013 and is headquartered in Nonthaburi, Thailand.
Full company profileSkin Laboratory PCL financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Skin Laboratory PCL annual financial statements (THB; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 282M | 272M | 229M | 177M | 132M |
| Gross Profit | 211M | 209M | 172M | 127M | 91.9M |
| Operating Income | 13.3M | 20.3M | 13.5M | 5.74M | -28.6M |
| EBITDA | 14.8M | 22.3M | 16.1M | 7.49M | -26.9M |
| Net Income | 10.7M | 16.7M | 10.7M | 4.38M | -29.4M |
| EPS | 0.07 | 0.12 | 0.07 | 0.03 | -0.20 |
| Balance Sheet | |||||
| Total Assets | 101M | 105M | 85.1M | 124M | 103M |
| Total Liabilities | 29.7M | 32.7M | 23.5M | 22.3M | 16.2M |
| Shareholders' Equity | 71.7M | 72.1M | 61.7M | 101M | 86.5M |
| Cash & Short-term Investments | 36.8M | 41.2M | 27.8M | 72.4M | 56.8M |
| Cash Flow | |||||
| Operating Cash Flow | 4.76M | 26.6M | 4.61M | 12.5M | -32.8M |
| Capital Expenditure | 20.0K | 120K | 0.00 | 6.44K | 0.00 |
| Free Cash Flow | 4.74M | 26.4M | 4.61M | 12.5M | -32.8M |
| Ratios | |||||
| ROE | 14.9% | 23.2% | 17.3% | 4.3% | -34.0% |
| ROA | 10.6% | 15.9% | 12.5% | 3.5% | -28.6% |
| Net Profit Margin | 3.8% | 6.1% | 4.7% | 2.5% | -22.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Skin Laboratory PCL dividends
- Dividend yield
- 14.69%
- Forward dividend
- -
- Payout ratio
- 376.9%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | THB 16.5M | 0.11 | 376.9% |
| 2024 | THB 70.0M | 0.49 | 656.1% |
| 2023 | THB 16.0M | 0.11 | 95.8% |
| 2022 | THB 13.1M | 0.09 | 122.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Skin Laboratory PCL
- Insiders 77.50%
- Institutions 0.00%
- Public & others 22.51%
- Shares outstanding 144M
- Free float 41.0M
Skin Laboratory PCL company profile
- Company name
- Skin Laboratory PCL
- Ticker
- SKIN.BK
- Exchange
- Thailand Exchange
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Employees
- 30
- Fiscal year end
- December
- Address
- No. 89, Cosmo Office Park Building, Nonthaburi, Thailand, 11120
- Phone
- 66 8 3597 9797
- Website
- skinlabth.com
About Skin Laboratory PCL
Skin Laboratory Public Company Limited manufactures and distributes beauty products in Thailand and internationally. The company offers skincare products, beauty creams, cosmetics, and dietary supplements under the Skinsista and Dermie brand names. It sells its products through online channels and stores. The company was incorporated in 2013 and is headquartered in Nonthaburi, Thailand.
Skin Laboratory PCL management
7- Mr. Chanvit KhieonavavongsaCEO, Vice Chairman & Acting Chief Accounting and Finance Officer · born 1978
- Ms. Nathaporn PhongcharnchawalitCOO, Acting Company Secretary, Head of Investor Relations & Director · born 1985
- Ms. Kannika PluemaromChief Marketing Officer · born 1991
- Ms. Nuntinart PhongcharnchawalitGM of Purchasing & Human Resources Manager · born 1986
- Mr. Tanongsak PadistarnHead of Internal Audit · born 1981
- Ms. Supathra ThiampicharnCompany Secretary
- Ms. Tippawan KhantaleeGM of Accounting & Finance Division · born 1993